Difference between revisions of "Template:Chemokine receptor modulators"
Jump to navigation
Jump to search
imported>Frietjes |
imported>Medgirl131 |
||
| Line 158: | Line 158: | ||
* [[Ubiquitin]] | * [[Ubiquitin]] | ||
| − | * ''Antagonists:'' [[Plerixafor|Plerixafor (AMD3100)]] | + | * ''Antagonists:'' [[Mavorixafor]] |
| + | * [[Plerixafor|Plerixafor (AMD3100)]] | ||
* ''Antibodies:'' [[Ulocuplumab]] (against CXCR4) | * ''Antibodies:'' [[Ulocuplumab]] (against CXCR4) | ||
Latest revision as of 07:08, 19 June 2018
Initial visibility: currently defaults to autocollapse
To set this template's initial visibility, the |state= parameter may be used:
|state=collapsed:{{Chemokine receptor modulators|state=collapsed}}to show the template collapsed, i.e., hidden apart from its title bar|state=expanded:{{Chemokine receptor modulators|state=expanded}}to show the template expanded, i.e., fully visible|state=autocollapse:{{Chemokine receptor modulators|state=autocollapse}}
If the |state= parameter in the template on this page is not set, the template's initial visibility is taken from the |default= parameter in the Collapsible option template. For the template on this page, that currently evaluates to autocollapse.